# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-25-021286
Filing Date
2025-11-07
Accepted
2025-11-07 16:30:48
Documents
66
Period of Report
2025-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | form10-q.htm iXBRL | 10-Q | 763991
2 | EX-21.1 | ex21-1.htm | EX-21.1 | 12480
3 | EX-31.1 | ex31-1.htm | EX-31.1 | 18452
4 | EX-31.2 | ex31-2.htm | EX-31.2 | 18889
5 | EX-32.1 | ex32-1.htm | EX-32.1 | 10296
| Complete submission text file | 0001493152-25-021286.txt |  | 4645394

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL SCHEMA FILE | ibo-20250930.xsd | EX-101.SCH | 34889
7 | XBRL CALCULATION FILE | ibo-20250930_cal.xml | EX-101.CAL | 48823
8 | XBRL DEFINITION FILE | ibo-20250930_def.xml | EX-101.DEF | 139979
9 | XBRL LABEL FILE | ibo-20250930_lab.xml | EX-101.LAB | 283173
10 | XBRL PRESENTATION FILE | ibo-20250930_pre.xml | EX-101.PRE | 235649
68 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 657110

Mailing Address 1400 BROADFIELD BLVD. SUITE 130 HOUSTON TX 77084
Business Address 1400 BROADFIELD BLVD. SUITE 130 HOUSTON TX 77084 585 232 1500
IMPACT BIOMEDICAL INC. (Filer) CIK: 0001834105 (see all company filings)

EIN.: 853926944 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42212 | Film No.: 251463098
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)